CNTX
Price
$1.23
Change
-$0.03 (-2.38%)
Updated
Oct 27, 04:59 PM (EDT)
Capitalization
113.03M
9 days until earnings call
Intraday Buy/Sell Signals
PRQR
Price
$2.83
Change
-$0.07 (-2.41%)
Updated
Oct 27, 04:59 PM (EDT)
Capitalization
306.55M
9 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CNTX vs PRQR

Header iconCNTX vs PRQR Comparison
Open Charts CNTX vs PRQRBanner chart's image
Context Therapeutics
Price$1.23
Change-$0.03 (-2.38%)
Volume$3.87K
Capitalization113.03M
ProQR Therapeutics
Price$2.83
Change-$0.07 (-2.41%)
Volume$9.4K
Capitalization306.55M
CNTX vs PRQR Comparison Chart in %
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTX vs. PRQR commentary
Oct 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 28, 2025
Stock price -- (CNTX: $1.26 vs. PRQR: $2.91)
Brand notoriety: CNTX and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 39% vs. PRQR: 80%
Market capitalization -- CNTX: $113.03M vs. PRQR: $306.55M
CNTX [@Biotechnology] is valued at $113.03M. PRQR’s [@Biotechnology] market capitalization is $306.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNTX and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 6 bullish TA indicator(s).

  • CNTX’s TA Score: 4 bullish, 5 bearish.
  • PRQR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRQR is a better buy in the short-term than CNTX.

Price Growth

CNTX (@Biotechnology) experienced а -12.50% price change this week, while PRQR (@Biotechnology) price change was +4.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.52%. For the same industry, the average monthly price growth was +11.37%, and the average quarterly price growth was +65.39%.

Reported Earning Dates

CNTX is expected to report earnings on Nov 05, 2025.

PRQR is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($307M) has a higher market cap than CNTX($113M). CNTX YTD gains are higher at: 20.000 vs. PRQR (9.811). PRQR has higher annual earnings (EBITDA): -35.56M vs. CNTX (-38.29M). PRQR has more cash in the bank: 120M vs. CNTX (83.5M). CNTX has less debt than PRQR: CNTX (167K) vs PRQR (16.9M). PRQR has higher revenues than CNTX: PRQR (16.5M) vs CNTX (0).
CNTXPRQRCNTX / PRQR
Capitalization113M307M37%
EBITDA-38.29M-35.56M108%
Gain YTD20.0009.811204%
P/E RatioN/AN/A-
Revenue016.5M-
Total Cash83.5M120M70%
Total Debt167K16.9M1%
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTXPRQR
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
88%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NASC0.02N/A
+20.26%
Nascent Pharma Holdings Inc.
CMBNF91.31N/A
N/A
CEMBRA MONEY BK AG
HLFDF1.86N/A
N/A
Halfords Group Plc
XROLF96.73N/A
N/A
Xero Ltd.
GGLDF0.22-0.02
-7.14%
Getchell Gold Corporation

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and ORKA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and ORKA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-1.56%
ORKA - CNTX
32%
Poorly correlated
+0.44%
IPSC - CNTX
32%
Poorly correlated
-2.15%
GANX - CNTX
32%
Poorly correlated
+0.51%
PROK - CNTX
29%
Poorly correlated
+0.31%
PRQR - CNTX
29%
Poorly correlated
+3.19%
More